<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-13T09:07:23Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.19594" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.19594</identifier>
    <datestamp>2025-01-16T17:07:22Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2025-01-16</dc:date>
  <dc:title>N-3 polyunsaturated fatty acids prevent diabetic cardiomyopathy by promoting TET2-mediated DNA demethylation</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.19594</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>	Diabetes cardiomyopathy (DCM) has become an important complication of diabetes, and its pathogenesis is closely related to the disorder of active DNA methylation. It has been reported that n-3 polyunsaturated fatty acids (PUFAs) improved insulin resistance and cardiovascular function, however the underlay molecular mechanism is unknown. The mice were fed with high-fat diet and injected with STZ (55mg/kg/d) for 7 consecutive days. Diabetes mice were fed with high-fat diet for another 12 weeks to induce diabetes cardiomyopathy (DCM), DCM mice were then divided into four groups (n=15): DCM group (normal saline); metformin group (MET, 150 mg/kg/d metformin buffer); low-dose n-3 PUFAs group (Ln-3, 150 mg/kg/d); high-dose n-3 PUFAs group (Hn-3, 300 mg/kg/d). The control (CON) group was fed with a standard diet (normal saline). Fasting serum concentrations of insulin, total cholesterol (TC), triglycerides (TG), low-density lipoprotein levels (LDL-C), and the atherogenic index of plasma (AIP) were significantly lower in both Ln-3 and Hn-3 groups than in DCM group.&amp;nbsp;Total n-3 PUFAs and n-3/n-6 ratio in heart were significantly lower in DCM group than in&amp;nbsp;CON, Ln-3 and Hn-3 groups.&amp;nbsp;The ejection fraction (EF), fractional shortening (FS), early diastolic mitral annular velocity (E&amp;rsquo;/A&amp;rsquo;) were significantly&amp;nbsp;lower in DCM group than in&amp;nbsp;CON and Hn-3 groups. The left ventricular mass index (LV mass index) and left ventricular posterior wall thickness in systole (LVPW; s) were significantly lower in CON, Ln-3 and Hn-3 groups than in DCM group.&amp;nbsp;The protein expression levels of TET2 and p-AMPK&amp;alpha;/ AMPK&amp;alpha; in mice heart of the Hn-3 group were significantly higher than those in the DCM group. The ratio of &amp;alpha;-ketoglutarate to (succinate + fumarate) in the DCM group was significantly lower than that in the Ln-3 and Hn-3 groups. In conclusion, n-3 PUFAs prevented the occurrence of DCM by promoting TET2-mediated DNA demethylation in diabetic mice heart.</dc:description>
  <dc:subject>N-3 polyunsaturated fatty acids; Diabetic cardiomyopathy; Ten-eleven translocation 2; Active DNA demethylation; Tricarboxylic acid cycle.</dc:subject>
  <dc:creator>刘润</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>